Skip to content
Screener

Pulse Biosciences, Inc. PLSE Asset turnover

Asset turnover at other companies

Abbott logo
AbbottABT
0.5×-0.1×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.5×0.0×
Boston Scientific logo
Boston ScientificBSX
0.5×0.0×
AtriCure logo
AtriCureATRC
0.9×+0.1×
Medtronic logo
MedtronicMDT
0.4×0.0×
Merit Medical Systems logo
Merit Medical SystemsMMSI
0.6×0.0×

Other financials

Income statement

See full
Revenue$434.0K—
Gross profit$161.0K—
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.65B+156%
Enterprise value$2.55B+173%
P/S2,233.4×—

Profitability

See full
Gross margin-0.1%—
Operating margin-7,007.8%—
Net margin-6,755.8%—
FCF margin-5,180.4%—

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

total revenue/total assets=0×

Based on trailing twelve months.

The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026288

FAQ

What is Pulse Biosciences, Inc.'s asset turnover?
Pulse Biosciences, Inc. (PLSE) reported asset turnover of 0× in Q2 2026.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Pulse Biosciences, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude